Further support that the PERK branch of the UPR might be a promising therapeutic target comes from studies investigating ER stress related diseases, including Alzheimer’s Disease (AD), amyotrophic lateral disease (ALS), Parkinson’s Disease, and prion diseases [151,152]. The gene discussed is EIF2AK3; the disease is Alzheimer disease.